A nuclear odyssey: Fibroblast growth factor-2 (FGF-2) as a regulator of nuclear homeostasis in the nervous system

Cellular and Molecular Life Sciences

Volumn 72, Issue 9, 2015, Pages 1651-1662

  Förthmann, Benjamin ^a   Grothe, Claudia ^a,b   Claus, Peter ^a,b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b CENTER FOR SYSTEMS NEUROSCIENCE   (Germany)

Author keywords

Chromatin; FGF signaling; Isoforms; Neurotrophic factor; Nuclear protein; Parkinso s disease; SMN; Spinal muscular atrophy (SMA); Splicing

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; ISOPROTEIN;

ACTIVE TRANSPORT; ANIMAL; CELL NUCLEUS; HOMEOSTASIS; HUMAN; METABOLISM; NERVOUS SYSTEM; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; CELL NUCLEUS; FIBROBLAST GROWTH FACTOR 2; HOMEOSTASIS; HUMANS; NERVOUS SYSTEM; PROTEIN INTERACTION MAPS; PROTEIN ISOFORMS; SIGNAL TRANSDUCTION;

EID: 84931450677     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-014-1818-6     Document Type: Review

References (141)

1. Ornitz DM, Itoh N (2001) Fibroblast growth factors. Genome Biol 2:reviews3005-reviews3005.12. doi: 10.1186/gb-2001-2-3-reviews3005
2. Itoh N, Ornitz DM (2004) Evolution of the Fgf and Fgfr gene families. Trends Genet 20:563-569
3. Gospodarowicz D, Jones KL, Sato G (1974) Purification of a growth factor for ovarian cells from bovine pituitary glands. Proc Natl Acad Sci USA 71:2295-2299
4. Armelin HA (1973) Pituitary extracts and steroid hormones in the control of 3T3 cell growth. Proc Natl Acad Sci USA 70:2702-2706
5. Gambarini AG, Armelin HA (1982) Purification and partial characterization of an acidic fibroblast growth factor from bovine pituitary. J Biol Chem 257:9692-9697
6. Lobb RR, Harper JW, Fett JW (1986) Purification of heparin-binding growth factors. Anal Biochem 154:1-14
7. Baird A, Klagsbrun M (1991) The fibroblast growth factor family. Cancer Cells 3:239-243
8. Moscatelli D, Joseph-Silverstein J, Manejias R, Rifkin DB (1987) Mr 25,000 heparin-binding protein from guinea pig brain is a high molecular weight form of basic fibroblast growth factor. Proc Natl Acad Sci USA 84:5778-5782
9. Presta M, Rusnati M, Maier JA, Ragnotti G (1988) Purification of basic fibroblast growth factor from rat brain: identification of a Mr 22,000 immunoreactive form. Biochem Biophys Res Commun 155:1161-1172
10. Shing Y, Folkman J, Sullivan R, Butterfield C, Murray J, Klagsbrun M (1984) Heparin affinity: purification of a tumor-derived capillary endothelial cell growth factor. Science 223:1296-1299
11. Arnaud E, Touriol C, Boutonnet C, Gensac MC, Vagner S, Prats H, Prats AC (1999) A new 34-kilodalton isoform of human fibroblast growth factor 2 is cap dependently synthesized by using a non-AUG start codon and behaves as a survival factor. Mol Cell Biol 19:505-514
12. Florkiewicz RZ, Sommer A (1989) Human basic fibroblast growth factor gene encodes four polypeptides: three initiate translation from non-AUG codons. Proc Natl Acad Sci USA 86:3978-3981
13. Prats H, Kaghad M, Prats AC, Klagsbrun M, Lelias JM, Liauzun P, Chalon P, Tauber JP, Amalric F, Smith JA et al (1989) High molecular mass forms of basic fibroblast growth factor are initiated by alternative CUG codons. Proc Natl Acad Sci USA 86:1836-1840
14. Sorensen V, Nilsen T, Wiedlocha A (2006) Functional diversity of FGF-2 isoforms by intracellular sorting. BioEssays 28:504-514
15. Chlebova K, Bryja V, Dvorak P, Kozubik A, Wilcox WR, Krejci P (2009) High molecular weight FGF2: the biology of a nuclear growth factor. Cell Mol Life Sci 66:225-235
16. Vagner S, Gensac MC, Maret A, Bayard F, Amalric F, Prats H, Prats AC (1995) Alternative translation of human fibroblast growth factor 2 mRNA occurs by internal entry of ribosomes. Mol Cell Biol 15:35-44
17. Audigier S, Guiramand J, Prado-Lourenco L, Conte C, Gonzalez-Herrera IG, Cohen-Solal C, Recasens M, Prats AC (2008) Potent activation of FGF-2 IRES-dependent mechanism of translation during brain development. RNA 14:1852-1864
18. Touriol C, Morillon A, Gensac MC, Prats H, Prats AC (1999) Expression of human fibroblast growth factor 2 mRNA is post-transcriptionally controlled by a unique destabilizing element present in the 3-untranslated region between alternative polyadenylation sites. J Biol Chem 274:21402-21408
19. Touriol C, Roussigne M, Gensac MC, Prats H, Prats AC (2000) Alternative translation initiation of human fibroblast growth factor 2 mRNA controlled by its 3-untranslated region involves a Poly(A) switch and a translational enhancer. J Biol Chem 275:19361-19367
20. Florkiewicz RZ, Majack RA, Buechler RD, Florkiewicz E (1995) Quantitative export of FGF-2 occurs through an alternative, energy-dependent, non-ER/Golgi pathway. J Cell Physiol 162:388-399
21. Mignatti P, Morimoto T, Rifkin DB (1992) Basic fibroblast growth factor, a protein devoid of secretory signal sequence, is released by cells via a pathway independent of the endoplasmic reticulum-Golgi complex. J Cell Physiol 151:81-93
22. Temmerman K, Ebert AD, Muller HM, Sinning I, Tews I, Nickel W (2008) A direct role for phosphatidylinositol-4,5-bisphosphate in unconventional secretion of fibroblast growth factor 2. Traffic 9:1204-1217
23. Steringer JP, Bleicken S, Andreas H, Zacherl S, Laussmann M, Temmerman K, Contreras FX, Bharat TA, Lechner J, Muller HM, Briggs JA, Garcia-Saez AJ, Nickel W (2012) Phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2)-dependent oligomerization of fibroblast growth factor 2 (FGF2) triggers the formation of a lipidic membrane pore implicated in unconventional secretion. J Biol Chem 287:27659-27669
24. Steringer JP, Muller HM, Nickel W (2014) Unconventional secretion of fibroblast growth factor 2 - a novel type of protein translocation across membranes? J Mol Biol. doi: 10.1016/j.jmb.2014.07.012
25. Santiago JJ, Dangerfield AL, Rattan SG, Bathe KL, Cunnington RH, Raizman JE, Bedosky KM, Freed DH, Kardami E, Dixon IM (2010) Cardiac fibroblast to myofibroblast differentiation in vivo and in vitro: expression of focal adhesion components in neonatal and adult rat ventricular myofibroblasts. Dev Dyn 239:1573-1584
26. Jiang ZS, Jeyaraman M, Wen GB, Fandrich RR, Dixon IM, Cattini PA, Kardami E (2007) High- but not low-molecular weight FGF-2 causes cardiac hypertrophy in vivo; possible involvement of cardiotrophin-1. J Mol Cell Cardiol 42:222-233
27. Santiago JJ, McNaughton LJ, Koleini N, Ma X, Bestvater B, Nickel BE, Fandrich RR, Wigle JT, Freed DH, Arora RC, Kardami E (2014) High molecular weight fibroblast growth factor-2 in the human heart is a potential target for prevention of cardiac remodeling. PLoS One 9:e97281
28. Sensenbrenner M (1993) The neurotrophic activity of fibroblast growth factors. Prog Neurobiol 41:683-704
29. Barde YA (1989) Trophic factors and neuronal survival. Neuron 2:1525-1534
30. Grothe C, Unsicker K (1992) Basic fibroblast growth factor in the hypoglossal system: specific retrograde transport, trophic, and lesion-related responses. J Neurosci Res 32:317-328
31. Stoeckel K, Schwab M, Thoenen H (1975) Specificity of retrograde transport of nerve growth factor (NGF) in sensory neurons: a biochemical and morphological study. Brain Res 89:1-14
32. Johnson EM Jr, Taniuchi M, Clark HB, Springer JE, Koh S, Tayrien MW, Loy R (1987) Demonstration of the retrograde transport of nerve growth factor receptor in the peripheral and central nervous system. J Neurosci 7:923-929
33. Barde YA (1988) What, if anything, is a neurotrophic factor? Trends Neurosci 11:343-346
34. Giordano S, Sherman L, Lyman W, Morrison R (1992) Multiple molecular weight forms of basic fibroblast growth factor are developmentally regulated in the central nervous system. Dev Biol 152:293-303
35. Ratzka A, Baron O, Grothe C (2011) FGF-2 deficiency does not influence FGF ligand and receptor expression during development of the nigrostriatal system. PLoS One 6:e23564
36. Hensel N, Ratzka A, Brinkmann H, Klimaschewski L, Grothe C, Claus P (2012) Analysis of the fibroblast growth factor system reveals alterations in a mouse model of spinal muscular atrophy. PLoS One 7:e31202
37. Claus P, Werner S, Timmer M, Grothe C (2004) Expression of the fibroblast growth factor-2 isoforms and the FGF receptor 1-4 transcripts in the rat model system of Parkinson's disease. Neurosci Lett 360:117-120
38. Date I, Yoshimoto Y, Imaoka T, Miyoshi Y, Gohda Y, Furuta T, Asari S, Ohmoto T (1993) Enhanced recovery of the nigrostriatal dopaminergic system in MPTP-treated mice following intrastriatal injection of basic fibroblast growth factor in relation to aging. Brain Res 621:150-154
39. Otto D, Unsicker K (1990) Basic FGF reverses chemical and morphological deficits in the nigrostriatal system of MPTP-treated mice. J Neurosci 10:1912-1921
40. Timmer M, Cesnulevicius K, Winkler C, Kolb J, Lipokatic-Takacs E, Jungnickel J, Grothe C (2007) Fibroblast growth factor (FGF)-2 and FGF receptor 3 are required for the development of the substantia nigra, and FGF-2 plays a crucial role for the rescue of dopaminergic neurons after 6-hydroxydopamine lesion. J Neurosci 27:459-471
41. Grothe C, Schulze A, Semkova I, Muller-Ostermeyer F, Rege A, Wewetzer K (2000) The high molecular weight fibroblast growth factor-2 isoforms (21,000 mol. wt and 23,000 mol. wt) mediate neurotrophic activity on rat embryonic mesencephalic dopaminergic neurons in vitro. Neuroscience 100:73-86
42. Timmer M, Muller-Ostermeyer F, Kloth V, Winkler C, Grothe C, Nikkhah G (2004) Enhanced survival, reinnervation, and functional recovery of intrastriatal dopamine grafts co-transplanted with Schwann cells overexpressing high molecular weight FGF-2 isoforms. Exp Neurol 187:118-136
43. Bansal R, Pfeiffer SE (1997) FGF-2 converts mature oligodendrocytes to a novel phenotype. J Neurosci Res 50:215-228
44. Goddard DR, Berry M, Kirvell SL, Butt AM (2001) Fibroblast growth factor-2 inhibits myelin production by oligodendrocytes in vivo. Mol Cell Neurosci 18:557-569
45. Armstrong RC, Le TQ, Frost EE, Borke RC, Vana AC (2002) Absence of fibroblast growth factor 2 promotes oligodendroglial repopulation of demyelinated white matter. J Neurosci 22:8574-8585
46. Nindl W, Kavakebi P, Claus P, Grothe C, Pfaller K, Klimaschewski L (2004) Expression of basic fibroblast growth factor isoforms in postmitotic sympathetic neurons: synthesis, intracellular localization and involvement in karyokinesis. Neuroscience 124:561-572
47. Pasumarthi KB, Kardami E, Cattini PA (1996) High and low molecular weight fibroblast growth factor-2 increase proliferation of neonatal rat cardiac myocytes but have differential effects on binucleation and nuclear morphology. Evidence for both paracrine and intracrine actions of fibroblast growth factor-2. Circ Res 78:126-136
48. Bachis A, Mallei A, Cruz MI, Wellstein A, Mocchetti I (2008) Chronic antidepressant treatments increase basic fibroblast growth factor and fibroblast growth factor-binding protein in neurons. Neuropharmacology 55:1114-1120
49. Kajitani N, Hisaoka-Nakashima K, Morioka N, Okada-Tsuchioka M, Kaneko M, Kasai M, Shibasaki C, Nakata Y, Takebayashi M (2012) Antidepressant acts on astrocytes leading to an increase in the expression of neurotrophic/growth factors: differential regulation of FGF-2 by noradrenaline. PLoS One 7:e51197
50. Ji RR, Zhang Q, Zhang X, Piehl F, Reilly T, Pettersson RF, Hokfelt T (1995) Prominent expression of bFGF in dorsal root ganglia after axotomy. Eur J Neurosci 7:2458-2468
51. Li GD, Wo Y, Zhong MF, Zhang FX, Bao L, Lu YJ, Huang YD, Xiao HS, Zhang X (2002) Expression of fibroblast growth factors in rat dorsal root ganglion neurons and regulation after peripheral nerve injury. NeuroReport 13:1903-1907
52. Huber K, Meisinger C, Grothe C (1997) Expression of fibroblast growth factor-2 in hypoglossal motoneurons is stimulated by peripheral nerve injury. J Comp Neurol 382:189-198
53. Klimaschewski L, Meisinger C, Grothe C (1999) Localization and regulation of basic fibroblast growth factor (FGF-2) and FGF receptor-1 in rat superior cervical ganglion after axotomy. J Neurobiol 38:499-506
54. Danielsen N, Pettmann B, Vahlsing HL, Manthorpe M, Varon S (1988) Fibroblast growth factor effects on peripheral nerve regeneration in a silicone chamber model. J Neurosci Res 20:320-330
55. Aebischer P, Salessiotis AN, Winn SR (1989) Basic fibroblast growth factor released from synthetic guidance channels facilitates peripheral nerve regeneration across long nerve gaps. J Neurosci Res 23:282-289
56. Fujimoto E, Mizoguchi A, Hanada K, Yajima M, Ide C (1997) Basic fibroblast growth factor promotes extension of regenerating axons of peripheral nerve. In vivo experiments using a Schwann cell basal lamina tube model. J Neurocytol 26:511-528
57. Timmer M, Robben S, Muller-Ostermeyer F, Nikkhah G, Grothe C (2003) Axonal regeneration across long gaps in silicone chambers filled with Schwann cells overexpressing high molecular weight FGF-2. Cell Transpl 12:265-277
58. Grothe C, Meisinger C, Hertenstein A, Kurz H, Wewetzer K (1997) Expression of fibroblast growth factor-2 and fibroblast growth factor receptor 1 messenger RNAs in spinal ganglia and sciatic nerve: regulation after peripheral nerve lesion. Neuroscience 76:123-135
59. Meisinger C, Grothe C (1997) Differential regulation of fibroblast growth factor (FGF)-2 and FGF receptor 1 mRNAs and FGF-2 isoforms in spinal ganglia and sciatic nerve after peripheral nerve lesion. J Neurochem 68:1150-1158
60. Grothe C, Nikkhah G (2001) The role of basic fibroblast growth factor in peripheral nerve regeneration. Anat Embryol (Berl) 204:171-177
61. Jungnickel J, Claus P, Gransalke K, Timmer M, Grothe C (2004) Targeted disruption of the FGF-2 gene affects the response to peripheral nerve injury. Mol Cell Neurosci 25:444-452
62. Haastert K, Lipokatic E, Fischer M, Timmer M, Grothe C (2006) Differentially promoted peripheral nerve regeneration by grafted Schwann cells over-expressing different FGF-2 isoforms. Neurobiol Dis 21:138-153
63. Haastert K, Grosheva M, Angelova SK, Guntinas-Lichius O, Skouras E, Michael J, Grothe C, Dunlop SA, Angelov DN (2009) Schwann cells overexpressing FGF-2 alone or combined with manual stimulation do not promote functional recovery after facial nerve injury. J Biomed Biotechnol 2009:408794
64. Meisinger C, Grothe C (1997) Differential expression of FGF-2 isoforms in the rat adrenal medulla during postnatal development in vivo. Brain Res 757:291-294
65. Seidl K, Unsicker K (1989) Survival and neuritic growth of sympathoadrenal (chromaffin) precursor cells in vitro. Int J Dev Neurosci 7:465-473
66. Meisinger C, Zeschnigk C, Grothe C (1996) In vivo and in vitro effect of glucocorticoids on fibroblast growth factor (FGF)-2 and FGF receptor 1 expression. J Biol Chem 271:16520-16525
67. Grothe C, Meisinger C (1997) The multifunctionality of FGF-2 in the adrenal medulla. Anat Embryol (Berl) 195:103-111
68. Grothe C, Meisinger C, Holzschuh J, Wewetzer K, Cattini P (1998) Over-expression of the 18 kD and 21/23 kD fibroblast growth factor-2 isoforms in PC12 cells and Schwann cells results in altered cell morphology and growth. Brain Res Mol Brain Res 57:97-105
69. Davis JB, Stroobant P (1990) Platelet-derived growth factors and fibroblast growth factors are mitogens for rat Schwann cells. J Cell Biol 110:1353-1360
70. Watabe K, Fukuda T, Tanaka J, Toyohara K, Sakai O (1994) Mitogenic effects of platelet-derived growth factor, fibroblast growth factor, transforming growth factor-beta, and heparin-binding serum factor for adult mouse Schwann cells. J Neurosci Res 39:525-534
71. Dong Z, Sinanan A, Parkinson D, Parmantier E, Mirsky R, Jessen KR (1999) Schwann cell development in embryonic mouse nerves. J Neurosci Res 56:334-348
72. Hansen MR, Vijapurkar U, Koland JG, Green SH (2001) Reciprocal signaling between spiral ganglion neurons and Schwann cells involves neuregulin and neurotrophins. Hear Res 161:87-98
73. Kardami E, Detillieux K, Ma X, Jiang Z, Santiago JJ, Jimenez SK, Cattini PA (2007) Fibroblast growth factor-2 and cardioprotection. Heart Fail Rev 12:267-277
74. Sabbieti MG, Agas D, Marchetti L, Coffin JD, Xiao L, Hurley MM (2013) BMP-2 differentially modulates FGF-2 isoform effects in osteoblasts from newborn transgenic mice. Endocrinology 154:2723-2733
75. Xiao L, Esliger A, Hurley MM (2013) Nuclear fibroblast growth factor 2 (FGF2) isoforms inhibit bone marrow stromal cell mineralization through FGF23/FGFR/MAPK in vitro. J Bone Miner Res 28:35-45
76. Xiao L, Ueno D, Catros S, Homer-Bouthiette C, Charles L, Kuhn L, Hurley MM (2014) Fibroblast growth factor-2 isoform (low molecular weight/18 kDa) overexpression in preosteoblast cells promotes bone regeneration in critical size calvarial defects in male mice. Endocrinology 155:965-974
77. Quarto N, Talarico D, Florkiewicz R, Rifkin DB (1991) Selective expression of high molecular weight basic fibroblast growth factor confers a unique phenotype to NIH 3T3 cells. Cell Regul 2:699-708
78. Quarto N, Fong KD, Longaker MT (2005) Gene profiling of cells expressing different FGF-2 forms. Gene 356:49-68
79. Arese M, Chen Y, Florkiewicz RZ, Gualandris A, Shen B, Rifkin DB (1999) Nuclear activities of basic fibroblast growth factor: potentiation of low-serum growth mediated by natural or chimeric nuclear localization signals. Mol Biol Cell 10:1429-1444
80. Pasumarthi KB, Doble BW, Kardami E, Cattini PA (1994) Over-expression of CUG- or AUG-initiated forms of basic fibroblast growth factor in cardiac myocytes results in similar effects on mitosis and protein synthesis but distinct nuclear morphologies. J Mol Cell Cardiol 26:1045-1060
81. Claus P, Doring F, Gringel S, Muller-Ostermeyer F, Fuhlrott J, Kraft T, Grothe C (2003) Differential intranuclear localization of fibroblast growth factor-2 isoforms and specific interaction with the survival of motoneuron protein. J Biol Chem 278:479-485
82. Ma X, Dang X, Claus P, Hirst C, Fandrich RR, Jin Y, Grothe C, Kirshenbaum LA, Cattini PA, Kardami E (2007) Chromatin compaction and cell death by high molecular weight FGF-2 depend on its nuclear localization, intracrine ERK activation, and engagement of mitochondria. J Cell Physiol 213:690-698
83. Sheng Z, Lewis JA, Chirico WJ (2004) Nuclear and nucleolar localization of 18-kDa fibroblast growth factor-2 is controlled by C-terminal signals. J Biol Chem 279:40153-40160
84. Bugler B, Amalric F, Prats H (1991) Alternative initiation of translation determines cytoplasmic or nuclear localization of basic fibroblast growth factor. Mol Cell Biol 11:573-577
85. Quarto N, Finger FP, Rifkin DB (1991) The NH2-terminal extension of high molecular weight bFGF is a nuclear targeting signal. J Cell Physiol 147:311-318
86. Stewart M (2007) Molecular mechanism of the nuclear protein import cycle. Nat Rev Mol Cell Biol 8:195-208
87. Boulikas T (1993) Nuclear localization signals (NLS). Crit Rev Eukaryot Gene Expr 3:193-227
88. Dono R, James D, Zeller R (1998) A GR-motif functions in nuclear accumulation of the large FGF-2 isoforms and interferes with mitogenic signalling. Oncogene 16:2151-2158
89. Bruns AF, Grothe C, Claus P (2009) Fibroblast growth factor 2 (FGF-2) is a novel substrate for arginine methylation by PRMT5. Biol Chem 390:59-65
90. Claus P, Schulze E, Wisniewski JR (1994) Insect proteins homologous to mammalian high mobility group proteins I/Y (HMG I/Y). Characterization and binding to linear and four-way junction DNA. J Biol Chem 269:33042-33048
91. Huth JR, Bewley CA, Nissen MS, Evans JN, Reeves R, Gronenborn AM, Clore GM (1997) The solution structure of an HMG-I(Y)-DNA complex defines a new architectural minor groove binding motif. Nat Struct Biol 4:657-665
92. Burgess WH, Bizik J, Mehlman T, Quarto N, Rifkin DB (1991) Direct evidence for methylation of arginine residues in high molecular weight forms of basic fibroblast growth factor. Cell Regul 2:87-93
93. Pintucci G, Quarto N, Rifkin DB (1996) Methylation of high molecular weight fibroblast growth factor-2 determines post-translational increases in molecular weight and affects its intracellular distribution. Mol Biol Cell 7:1249-1258
94. Friesen WJ, Paushkin S, Wyce A, Massenet S, Pesiridis GS, Van Duyne G, Rappsilber J, Mann M, Dreyfuss G (2001) The methylosome, a 20S complex containing JBP1 and pICln, produces dimethylarginine-modified Sm proteins. Mol Cell Biol 21:8289-8300
95. Friesen WJ, Massenet S, Paushkin S, Wyce A, Dreyfuss G (2001) SMN, the product of the spinal muscular atrophy gene, binds preferentially to dimethylarginine-containing protein targets. Mol Cell 7:1111-1117
96. Brahms H, Meheus L, de Brabandere V, Fischer U, Luhrmann R (2001) Symmetrical dimethylation of arginine residues in spliceosomal Sm protein B/B' and the Sm-like protein LSm4, and their interaction with the SMN protein. RNA 7:1531-1542
97. Meister G, Eggert C, Buhler D, Brahms H, Kambach C, Fischer U (2001) Methylation of Sm proteins by a complex containing PRMT5 and the putative U snRNP assembly factor pICln. Curr Biol 11:1990-1994
98. Will CL, Luhrmann R (1997) Protein functions in pre-mRNA splicing. Curr Opin Cell Biol 9:320-328
99. Tripsianes K, Madl T, Machyna M, Fessas D, Englbrecht C, Fischer U, Neugebauer KM, Sattler M (2011) Structural basis for dimethylarginine recognition by the Tudor domains of human SMN and SPF30 proteins. Nat Struct Mol Biol 18:1414-1420
100. Bossard C, Laurell H, Van den Berghe L, Meunier S, Zanibellato C, Prats H (2003) Translokin is an intracellular mediator of FGF-2 trafficking. Nat Cell Biol 5:433-439
101. Maher PA (1996) Nuclear translocation of fibroblast growth factor (FGF) receptors in response to FGF-2. J Cell Biol 134:529-536
102. Reilly JF, Maher PA (2001) Importin beta-mediated nuclear import of fibroblast growth factor receptor: role in cell proliferation. J Cell Biol 152:1307-1312
103. Johnson HM, Subramaniam PS, Olsnes S, Jans DA (2004) Trafficking and signaling pathways of nuclear localizing protein ligands and their receptors. BioEssays 26:993-1004
104. Stachowiak MK, Fang X, Myers JM, Dunham SM, Berezney R, Maher PA, Stachowiak EK (2003) Integrative nuclear FGFR1 signaling (INFS) as a part of a universal "feed-forward-and-gate" signaling module that controls cell growth and differentiation. J Cell Biochem 90:662-691
105. Coleman SJ, Chioni AM, Ghallab M, Anderson RK, Lemoine NR, Kocher HM, Grose RP (2014) Nuclear translocation of FGFR1 and FGF2 in pancreatic stellate cells facilitates pancreatic cancer cell invasion. EMBO Mol Med 6:467-481
106. Marchetti L, Sabbieti MG, Agas D, Menghi M, Materazzi G, Menghi G, Hurley MM (2006) PGF2alpha increases FGF-2 and FGFR2 trafficking in Py1a rat osteoblasts via clathrin independent and importin beta dependent pathway. J Cell Biochem 97:1379-1392
107. Hebert MD, Shpargel KB, Ospina JK, Tucker KE, Matera AG (2002) Coilin methylation regulates nuclear body formation. Dev Cell 3:329-337
108. Dundr M, Misteli T (2001) Functional architecture in the cell nucleus. Biochem J 356:297-310
109. Sleeman JE, Lamond AI (1999) Newly assembled snRNPs associate with coiled bodies before speckles, suggesting a nuclear snRNP maturation pathway. Curr Biol 9:1065-1074
110. Liu Q, Dreyfuss G (1996) A novel nuclear structure containing the survival of motor neurons protein. EMBO J 15:3555-3565
111. Bruns AF, van Bergeijk J, Lorbeer C, Nolle A, Jungnickel J, Grothe C, Claus P (2009) Fibroblast growth factor-2 regulates the stability of nuclear bodies. Proc Natl Acad Sci USA 106:12747-12752
112. Förthmann B, Brinkmann H, Ratzka A, Stachowiak MK, Grothe C, Claus P (2013) Immobile survival of motoneuron (SMN) protein stored in Cajal bodies can be mobilized by protein interactions. Cell Mol Life Sci 70:2555-2568
113. Sun G, Doble BW, Sun JM, Fandrich RR, Florkiewicz R, Kirshenbaum L, Davie JR, Cattini PA, Kardami E (2001) CUG-initiated FGF-2 induces chromatin compaction in cultured cardiac myocytes and in vitro. J Cell Physiol 186:457-467
114. Gringel S, van Bergeijk J, Haastert K, Grothe C, Claus P (2004) Nuclear fibroblast growth factor-2 interacts specifically with splicing factor SF3a66. Biol Chem 385:1203-1208
115. Shen B, Arese M, Gualandris A, Rifkin DB (1998) Intracellular association of FGF-2 with the ribosomal protein L6/TAXREB107. Biochem Biophys Res Commun 252:524-528
116. Van den Berghe L, Laurell H, Huez I, Zanibellato C, Prats H, Bugler B (2000) FIF [fibroblast growth factor-2 (FGF-2)-interacting-factor], a nuclear putatively antiapoptotic factor, interacts specifically with FGF-2. Mol Endocrinol 14:1709-1724
117. Krejci P, Pejchalova K, Rosenbloom BE, Rosenfelt FP, Tran EL, Laurell H, Wilcox WR (2007) The antiapoptotic protein Api5 and its partner, high molecular weight FGF2, are up-regulated in B cell chronic lymphoid leukemia. J Leukoc Biol 82:1363-1364
118. Claus P, Bruns AF, Grothe C (2004) Fibroblast growth factor-2(23) binds directly to the survival of motoneuron protein and is associated with small nuclear RNAs. Biochem J 384:559-565
119. McAndrew PE, Parsons DW, Simard LR, Rochette C, Ray PN, Mendell JR, Prior TW, Burghes AH (1997) Identification of proximal spinal muscular atrophy carriers and patients by analysis of SMNT and SMNC gene copy number. Am J Hum Genet 60:1411-1422
120. Feldkotter M, Schwarzer V, Wirth R, Wienker TF, Wirth B (2002) Quantitative analyses of SMN1 and SMN2 based on real-time lightCycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy. Am J Hum Genet 70:358-368
121. Terns MP, Terns RM (2001) Macromolecular complexes: SMN - the master assembler. Curr Biol 11:R862-R864
122. Baumer D, Lee S, Nicholson G, Davies JL, Parkinson NJ, Murray LM, Gillingwater TH, Ansorge O, Davies KE, Talbot K (2009) Alternative splicing events are a late feature of pathology in a mouse model of spinal muscular atrophy. PLoS Genet 5:e1000773
123. Coovert DD, Le TT, McAndrew PE, Strasswimmer J, Crawford TO, Mendell JR, Coulson SE, Androphy EJ, Prior TW, Burghes AH (1997) The survival motor neuron protein in spinal muscular atrophy. Hum Mol Genet 6:1205-1214
124. Andrade LE, Chan EK, Raska I, Peebles CL, Roos G, Tan EM (1991) Human autoantibody to a novel protein of the nuclear coiled body: immunological characterization and cDNA cloning of p80-coilin. J Exp Med 173:1407-1419
125. Hebert MD, Szymczyk PW, Shpargel KB, Matera AG (2001) Coilin forms the bridge between Cajal bodies and SMN, the spinal muscular atrophy protein. Genes Dev 15:2720-2729
126. Tucker KE, Berciano MT, Jacobs EY, LePage DF, Shpargel KB, Rossire JJ, Chan EK, Lafarga M, Conlon RA, Matera AG (2001) Residual Cajal bodies in coilin knockout mice fail to recruit Sm snRNPs and SMN, the spinal muscular atrophy gene product. J Cell Biol 154:293-307
127. Stanek D, Neugebauer KM (2006) The Cajal body: a meeting place for spliceosomal snRNPs in the nuclear maze. Chromosoma 115:343-354
128. Sen A, Yokokura T, Kankel MW, Dimlich DN, Manent J, Sanyal S, Artavanis-Tsakonas S (2011) Modeling spinal muscular atrophy in Drosophila links Smn to FGF signaling. J Cell Biol 192:481-495
129. Förthmann B, van Bergeijk J, Lee YW, Lubben V, Schill Y, Brinkmann H, Ratzka A, Stachowiak MK, Hebert M, Grothe C, Claus P (2013) Regulation of neuronal differentiation by proteins associated with nuclear bodies. PLoS One 8:e82871
130. Thau N, Jungnickel J, Knippenberg S, Ratzka A, Dengler R, Petri S, Grothe C (2012) Prolonged survival and milder impairment of motor function in the SOD1 ALS mouse model devoid of fibroblast growth factor 2. Neurobiol Dis 47:248-257
131. Fang X, Stachowiak EK, Dunham-Ems SM, Klejbor I, Stachowiak MK (2005) Control of CREB-binding protein signaling by nuclear fibroblast growth factor receptor-1: a novel mechanism of gene regulation. J Biol Chem 280:28451-28462
132. Coleman SJ, Bruce C, Chioni AM, Kocher HM, Grose RP (2014) The ins and outs of fibroblast growth factor receptor signalling. Clin Sci (Lond) 127:217-231
133. Dunham-Ems SM, Lee YW, Stachowiak EK, Pudavar H, Claus P, Prasad PN, Stachowiak MK (2009) Fibroblast growth factor receptor-1 (FGFR1) nuclear dynamics reveal a novel mechanism in transcription control. Mol Biol Cell 20:2401-2412
134. Stachowiak MK, Maher PA, Stachowiak EK (2007) Integrative nuclear signaling in cell development - a role for FGF receptor-1. DNA Cell Biol 26:811-826
135. Baron O, Forthmann B, Lee YW, Terranova C, Ratzka A, Stachowiak EK, Grothe C, Claus P, Stachowiak MK (2012) Cooperation of nuclear fibroblast growth factor receptor 1 and Nurr1 offers new interactive mechanism in postmitotic development of mesencephalic dopaminergic neurons. J Biol Chem 287:19827-19840
136. Cioce M, Lamond AI (2005) Cajal bodies: a long history of discovery. Annu Rev Cell Dev Biol 21:105-131
137. Sleeman JE, Trinkle-Mulcahy L, Prescott AR, Ogg SC, Lamond AI (2003) Cajal body proteins SMN and Coilin show differential dynamic behaviour in vivo. J Cell Sci 116:2039-2050
138. Sleeman JE, Ajuh P, Lamond AI (2001) snRNP protein expression enhances the formation of Cajal bodies containing p80-coilin and SMN. J Cell Sci 114:4407-4419
139. Morris GE (2008) The Cajal body. Biochim Biophys Acta 1783:2108-2115
140. Matera AG, Izaguire-Sierra M, Praveen K, Rajendra TK (2009) Nuclear bodies: random aggregates of sticky proteins or crucibles of macromolecular assembly? Dev Cell 17:639-647
141. Hebert MD (2010) Phosphorylation and the Cajal body: modification in search of function. Arch Biochem Biophys 496:69-76